Диспансерное наблюдение
Пациенты с ХСН подлежат диспансерному наблюдению, не реже 1 раза в
2 месяца или чаще, если это определяется клинической ситуацией или
ухудшением течения основного заболевания. Пациенты, перенесшие
трансплантацию сердца, подлежат пожизненному диспансерному наблюдению,
не реже 1 раза в месяц.
Список литературы:
1.
Chronic heart failure in adults: diagnosis and management. NICE (National
Institute for Health and care Excellence) guideline, 2018. – P 1-38.
2.
Ponikowski P., Voors A.A., Anker S.D. et al. Guidelines for the diagnosis and
treatment Acute and Chronic Heart Failure: The Task Force for the diagnosis
and treatment of acute and chronic heart failure of the European Society of
Cardiology (ESC). Developed with the special contribution of the Heart
Failure Association (HFA) of the ESC // Eur Heart J. 2016. – P 1-85.
3.
Yancy C.W., Jessup M., Masoudi F.A. et al. 2017 ACC/AHA/HFSA Focused
Update of the 2013 ACCF/AHA Guideline for the Management of Heart
Failure. A Report of the American College of Cardiology/American Heart
Association Task Force on Clinical Practice Guidelines and the Heart Failure
Society of America // Circulation 2017. – Р 137-161.
4.
Konstam M.A., Kiernan M.S., Bernstein D. et al. Evaluation and Management
of Right-Sided Heart Failure. A Scientific Statement From the American Heart
Association Endorsed by the Heart Failure Society of America and
International Society for Heart and Lung Transplantation // Circulation 2018. –
P 1-47.
5.
Bayes-Genis А., de Antonio M., Vila J. et al. Head-to-Head Comparison of 2
Myocardial Fibrosis Biomarkers for Long-Term Heart Failure Risk
Stratification // J Am Coll Cardiol 2014. - №63. – Р 158–66.
6.
Aleksova A., Paldino A., Beltrami A. et al. Cardiac Biomarkers in the
Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart
Failureand Acute Coronary Syndrome—There is Meat on the Bone // J. Clin.
Med. 2019. - №8. - Р 270
7.
Choudhary R., Shah K., Maisel A. Biomarkers in acute heart failure. The ESC
Textbook of Intensive and Acute Cardiovascular Care (2 ed.). 2018 February.
8.
Meijers W. C., Januzzi J.L., Defilippi, C. et al. Elevated plasma galectin-3 is
associated with near-term rehospitalization in heart failure:A pooled analysis
of 3 clinical trials // Am Heart J. 2014 Jun. – 167(6). – Р 853-60. e4
133
9.
Imran T.F., Shin H.J., Mathenge N. et al. Meta-Analysis of the Usefulness of
Plasma Galectin-3 to Predict the Risk of Mortality in Patients With Heart
Failure and in the General Population // Am J Cardiol. 2017 Jan 1. – 119(1). –
Р 57-64.
10.
Januzzi J.L., Mebazaa A., Di Somma S. ST2 and Prognosis in Acutely
Decompensated Heart Failure:The International ST2 Consensus Panel. // Am.
J. Cardiol 2015. – 115. –Р 26–31.
11.
Kormos R.L., Cowger J., Pagani F.D. et al. The Society of Thoracic Surgeons
Intermacs Database Annual Report: Evolving Indications, Outcomes, and
Scientific Partnerships // Ann ThoracSurg 2019. - 107(2). – Р 341-353.
12.
Bourque K, Cotter C, Dague C, et al. Design Rationale and Preclinical
Evaluation of the HeartMate 3 Left Ventricular Assist System for
Hemocompatibility // American Society of Artificial Internal Organs 2016. -
№62. - Р. 375–383.
13.
Mehra M.R., Goldstein D.J., Uriel N., et al. Two-Year Outcomes with a
Magnetically Levitated Cardiac Pump in Heart Failure // N Engl J Med 2018. -
№378(15). - Р. 1386-1395.
14.
Lim H.S., Howell N., Ranasinghe A. The Physiology of Continuous-Flow Left
Ventricular Assist Devices // Journal of Cardiac Failure 2 February 2017. -
Vol. 23 No 2 – P170-171.
15.
Amsallem M, Mercier O., Kobayashi Y., Moneghetti K., Haddad F. A Focused
Update on the Right Ventricle in Cardiovascular Disease // JACC Heart Fail
2018 -№6. –Р. 891-903.
16.
Bellavia D, Iacovoni A, Scardulla C, Moja L, Pilato M et al. Prediction of right
ventricular failure after ventricular assist device implant: systematic review and
meta-analysis of observational studies // Eur J Heart Fail 2017 -№19. –Р. 926-
946.
17.
Pamela S. Douglas, Blase A. Carabello, Roberto M. Lang, Leo Lopez et al.
2019 ACC/AHA/ASE Key Data Elements and Definitions for Transthoracic
Echocardiography: A Report of the American College of Cardiology/American
Heart Association Task Force on Clinical Data Standards (Writing Committee
to Develop Clinical Data Standards for Transthoracic Echocardiography) and
the American Society of Echocardiography // Circulation: Cardiovascular
Imaging 2019. -№12. –Р. 1-68.
18.
Marianna Adamo, Carlo Mario Lombardi, Marco Metra et al. Chronic and
acute heart failure: from epidemiology to treatment // European Journal of
Heart Failure 2019. -№21. –Р. 1879-0844
19.
Nishimura RA, Otto CM, Bonow RO, Carabello BA et al. American College of
Cardiology/American
Heart
Association
Task
Force
on
Practice
Guidelines. 2014 AHA/ACC guideline for the management of patients with
valvular heart disease: executive summary: a report of the American College of
Cardiology // American Heart Association Task Force on Practice
Guidelines. J Am Coll Cardiol 2014. -№63. –Р. 2438–2488.
134
20.
Butler J, Fonarow GC, Zile MR, Lam CS at al. Developing therapies for heart
failure with preserved ejection fraction: current state and future directions //
JACC Heart Fail 2014. -№2. –Р. 97–112.
21.
Rahimi K, Bennett D, Conrad N, Williams TM et al. Risk prediction in patients
with heart failure // JACC Heart Fail 2014. -№2. –Р. 440–446.
22.
Ouwerkerk W , Voors AA, Zwinderman AH.
Factors
influencing
the
predictive power of models for predicting mortality and/or heart-failure
hospitalization in patients with heart failure // JACC Heart Fail 2014. -№2. –Р.
429–436.
23.
Windecker S , Kolh P, Alfonso F, Collet JP, Cremer J, Falk V
et
al. 2014
ESC/EACTS Guidelines on myocardial revascularization: the Task Force on
Myocardial Revascularization of the European Society of Cardiology (ESC)
and the European Association for Cardio-Thoracic Surgery (EACTS).
Developed with the special contribution of the European Association of
Percutaneous Cardiovascular Interventions (EAPCI) // Eur Heart J 2014. -
№35. –Р. 2541–2619.
24.
Elliott P.M., Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P et
al. 2014 ESC Guidelines on diagnosis and management of hypertrophic
cardiomyopathy: the Task Force for the Diagnosis and Management of
Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) //
Eur Heart J 2014. -№35. –Р. 2733–2779.
25.
Arbustini E , Narula N, Tavazzi L, Serio A, Grasso M, Favalli V, Bellazzi R, T
ajik JABonow
RD, Fuster V, Narula J. The
MOGE(S)
classification
of
cardiomyopathy for clinicians // J Am Coll Cardiol 2014. –№64. –Р. 304–318.
26.
King J.B., Bress AP, Reese AD, Munger MA. Neprilysin inhibition in heart
failure with reduced ejection fraction: a clinical review // Pharmacother J Hum
Pharmacol Drug Ther 2015. -№35. –Р. 823–837.
27.
Pitt B , Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B
et
al.
Spironolactone for heart failure with preserved ejection fraction // N Engl J
Med 2014. -№370. –Р. 1383–1392.
28.
Sakata Y , Shiba N, Takahashi J, Miyata S, Nochioka K, Miura M, Takada T, S
agaC, Shinozaki T et al. Clinical impacts of additive use of olmesartan in
hypertensive patients with chronic heart failure: the supplemental benefit of an
angiotensin receptor blocker in hypertensive patients with stable heart failure
using olmesartan (SUPPORT) trial // Eur Heart J 2015. -№36. –Р. 915–923.
29.
Turakhia MP , Ullal AJ, Hoang DD, Than CT, Miller JD, Friday KJ, Perez M
V, Freeman JV et al. Feasibility of extended ambulatory electrocardiogram
monitoring to identify silent atrial fibrillation in high-risk patients: the
Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF) // Clin
Cardiol 2015. –№38. –Р. 285–292.
30.
Cintra FD , Leite RP, Storti LJ, Bittencourt LA, Poyares D, Castro L
de
S, Tufik , Paola A de. Sleep apnea and nocturnal cardiac arrhythmia: a
populational study // Arq Bras Cardiol 2014. -№103. –Р. 368–374.
135
31.
Gilat H , Vinker S, Buda I, Soudry E, Shani M, Bachar G. Obstructive sleep
apnea and cardiovascular comorbidities: a large epidemiologic study //
Medicine (Baltimore) 2014. -№93. –Р. e45
32.
Padwal R , McAlister F a, McMurray JJ V et al. The obesity paradox in heart
failure patients with preserved versus reduced ejection fraction: a meta-analysis
of individual patient data // Int J Obes 2014. -№38. –Р. 1110–1114
33.
Damman K , Valente , Voors AA, O'Connor CM, van
Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and
outcome in patients with heart failure: an updated meta-analysis // Eur Heart J
2014. -№35. –Р. 455–469.
34.
Filippatos G , Farmakis D, Parissis J. Renal dysfunction and heart failure:
things are seldom what they seem //
Достарыңызбен бөлісу: |